Predict your next investment

Venture Capital
npv.vc

See what CB Insights has to offer

Investments

87

Portfolio Exits

10

Service Providers

1

About Northpond Ventures

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, MD.

Northpond Ventures Headquarter Location

7500 Old Georgetown Road Suite 850

Bethesda, Maryland, 20814,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Northpond Ventures News

MIT-Northpond Program Created to Advance Innovation in Engineering and Life Science

Jun 15, 2022

June 15, 2022 09:00 AM Eastern Daylight Time CAMBRIDGE, Mass.--( BUSINESS WIRE )--MIT School of Engineering and Northpond Ventures today announced the launch of the MIT-Northpond Program – Advancing Life Science & Engineering Innovation. The five-year engagement is funded through Northpond Labs, the research and development-focused affiliate of Northpond Ventures . The program aims to generate ideas in the life sciences by connecting Northpond’s experienced venture capital investors with MIT’s scientific entrepreneurs, advancing commercialization through close mentorship and collaboration. Centered within the Department of Biological Engineering, the program will identify MIT researchers engaging in proof-of-concept research projects in the areas of diagnostics, R&D solutions, platforms for therapeutic solutions, biomanufacturing, and AI and software for treatment selection, all with the goal of commercializing their ideas. “This unique program was established with the intent to couple incredible advancements in engineering and biology with innovative entrepreneurial and business opportunities. There is tremendous potential for the MIT-Northpond Program to impact human health by accelerating and commercializing visionary breakthroughs in engineering and life science,” said Anantha P. Chandrakasan, dean of the MIT School of Engineering and Vannevar Bush Professor of Electrical Engineering and Computer Science. The MIT-Northpond Program will support postdoctoral fellows working at the intersection of engineering and life science and provide mentorship for faculty and students. The program will also provide funding to the School of Engineering for its work in the life sciences. “We are honored to be a part of this incredible collaboration and to have the opportunity to provide our faculty, postdoctoral fellows, and students working at the intersection of engineering and biology, with the chance to drive fundamental change and impact,” said Angela Belcher, head of the Department of Biological Engineering, the James Mason Crafts Professor of Biological Engineering and Materials Science, and member of the Koch Institute for Integrative Cancer Research. The MIT-Northpond Program will include the following: Funding up to five translational research projects per year, moving from proof-of-concept to commercialization. Supporting two postdoctoral fellows in the Department of Biological Engineering each year through the School of Engineering’s Postdoctoral Fellowship Program for Excellence, with an emphasis on underrepresented groups, including women. Two faculty mentors will also receive support. Providing discretionary support to the School of Engineering for critical work and advancements in the life sciences. “We have a shared mission and vision to promote and advance science and engineering and to make a marked impact on humanity. We see ourselves as a part of an ecosystem with the potential to advance engineering, science, innovation, and entrepreneurship,” said Michael Rubin, founder and CEO of Northpond Ventures, who will also serve as a visiting scholar in the Department of Biological Engineering. Ernest Fraenkel will serve as faculty lead for the MIT-Northpond Program. Fraenkel is a professor in the Department of Biological Engineering and a member of the Computer Science and Artificial Intelligence Laboratory and the Broad Institute. The program will also include a joint steering committee, comprised of members from both MIT and Northpond where Belcher and Rubin will serve as co-chairs. “Through this program, we can provide transformational entrepreneurial and business opportunities to MIT’s incredible engineering and science talent,” said Sharon Kedar, co-founder and partner of Northpond Ventures. “Together, we will be able to impact humanity.” About Northpond Ventures Northpond Ventures is a multi-billion-dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has been named one of the three most active lead biotech investors in 2021 by Crunchbase, and the most active lead investor in life science solutions and molecular diagnostics by Silicon Valley Bank. It is particularly engaged in the research ecosystem, having led over 50 financings over the past several years, a high percentage of which have an academic origin. Learn more at npv.vc . About MIT School of Engineering The MIT School of Engineering’s mission is to educate the next generation of engineering leaders, to create new knowledge, and to serve society. Learn more at engineering.mit.edu . Contacts

Northpond Ventures Investments

87 Investments

Northpond Ventures has made 87 investments. Their latest investment was in Molecule as part of their Seed VC on June 6, 2022.

CBI Logo

Northpond Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/13/2022

Seed VC

Molecule

$13M

Yes

1

6/7/2022

Series A

Code Biotherapeutics

$75M

Yes

7

5/5/2022

Series C

Vizgen

$85.2M

No

3

4/28/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

4/11/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/13/2022

6/7/2022

5/5/2022

4/28/2022

4/11/2022

Round

Seed VC

Series A

Series C

Series B

Series A

Company

Molecule

Code Biotherapeutics

Vizgen

Subscribe to see more

Subscribe to see more

Amount

$13M

$75M

$85.2M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

7

3

10

10

Northpond Ventures Portfolio Exits

10 Portfolio Exits

Northpond Ventures has 10 portfolio exits. Their latest portfolio exit was Nanoview Biosciences on May 04, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/4/2022

Acquired

$99M

1

1/7/2022

IPO

$99M

Public

7

12/23/2021

Acquired

$99M

12

10/12/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

10/8/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/4/2022

1/7/2022

12/23/2021

10/12/2021

10/8/2021

Exit

Acquired

IPO

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

1

7

12

10

10

Northpond Ventures Acquisitions

1 Acquisition

Northpond Ventures acquired 1 company. Their latest acquisition was Saama Technologies on October 20, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/20/2021

Debt

$99M

$79.25M

Acq - Fin

14

Date

10/20/2021

Investment Stage

Debt

Companies

Valuation

$99M

Total Funding

$79.25M

Note

Acq - Fin

Sources

14

Northpond Ventures Service Providers

1 Service Provider

Northpond Ventures has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Northpond Ventures Team

4 Team Members

Northpond Ventures has 4 team members, including current Founder, Chief Executive Officer, Michael P. Rubin.

Name

Work History

Title

Status

ShaRon Kedar

Sands Capital, and McKinsey & Company

Founder

Current

Micheal Rubin

Founder

Current

Michael P. Rubin

Sands Capital, and Sands Capital Ventures

Founder, Chief Executive Officer

Current

Patrick Smerkers

Chief Financial Officer

Current

Name

ShaRon Kedar

Micheal Rubin

Michael P. Rubin

Patrick Smerkers

Work History

Sands Capital, and McKinsey & Company

Sands Capital, and Sands Capital Ventures

Title

Founder

Founder

Founder, Chief Executive Officer

Chief Financial Officer

Status

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.